Skip to content
Contact us

EU and UK Qualified Person Services

Our well-established QP services help to streamline your product’s journey from clinical trial to market release in the EU and UK, giving you the confidence that your investigational or commercial drug product have been processed and released in compliance with local GMP regulations.

Our services:

Our QP services for both investigational and commercial drug products help you meet the unique and complex regulatory demands of the EU and UK.

Sharp holds the required Manufacturing and Import Authorization (MIA) licenses to support you with the import and distribution of medicinal products into the EU and/or the UK. Our QP’s take responsibility for the batch certification and release of investigational medicinal product (IMP) for use in clinical trials and of medicinal products for commercial distribution. 

Our highly experienced QPs can accept personal and legal responsibility, as defined by European and UK legislation, that the medicinal products entering the EU and UK market under their review, have been processed following the principles of good manufacturing practice (GMP) as well as manufactured in accordance to their Marketing Authorization.

Batch release to market is often seen as the very end of the manufacturing process, but in reality, it begins much earlier than that. Fully establishing the upstream release process means QP certification can be awarded with much greater degree of confidence.

UK QP Oversight Process

From 1 January 2022 onwards, importing Investigational Medicinal Products (IMP) from countries on a list (EAA and EU countries) to Great Britain, will require a QP Oversight process. Sharp can also support you in overcoming the additional complexity when importing your finished clinical trial material from the EU to the UK.

We can also work with you to manage the storage and distribution of your products.

Our Solutions

Qualified Person and regulatory services for clinical and commercial batches (EU/UK)

  • Supply chain auditing
  • Auditing to GMP/GLP/PICs
  • Production of QP 3rd party declarations
  • Batch certification of IMP
  • Batch approval and release
  • Issuing Certificate of Release to allow EU and/or UK distribution of authorized drugs
  • QP GMP certification of IMP undertaken by Sharp
  • QP GMP certification of Active Substance for registration
  • IMPD support (simplified, full, compliance review)
  • Regulatory advice support
  • Consultation with a QP
  • UK QP oversight process (import from the EU 1. Jan. 2022 onwards)

Quality Infrastructure 

QualityOne Quality Management System (QMS)

Clinical Services Inquiry

Would you like to find out more about our clinical services? Fill the form below so we know what area you’re interested in and we’ll be very happy to help.

"*" indicates required fields

What service area are you interested in?
How did you hear about us?

[1]Sharp takes your privacy seriously and will only use your personal information to provide services that you have requested from us. We will not share your personal information with non-agent third parties. View our privacy policy here

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

To find out more about our clinical services, please contact: Michael MacNeir, Vice President Business Development

Trusted by many

“The people at Sharp are collaborative, responsive and always willing to accommodate our needs, and this is something to be admired. If they say they can do something, they will deliver no matter what – ultimately, their success is our success, and vice versa.”

Sr Quality Supplier Manager, Top 10 Pharmaceutical Company

“Sharp’s responsiveness and flexibility are truly gold standard. Their dedication to the core values of quality and service allows for a true partnership and success in getting our product to patients in need.

External Manufacturing, Top Mid-size Pharma Company

“Sharp is an exceptional partner in the packaging CMO space. They have a dedicated launch team which is unique and a huge benefit vs. having the project lead that handles commercial business also manage the launches. Launches can be very time consuming and they can focus on these activities vs. having to also manage the commercial side.

Top 10 Pharmaceutical Company
Our experience is your strength
Contact us